Social network
  • Understanding science, discovering

    Understanding science and discovering

  • Developing and marketing innovative solutions

    Developing and marketing innovative solutions

  • Manufacturing and supply

    Manufacturing and supply

     

    New molecule licensing

    We are open to partnerships that can bring a specific compound to complement our development portfolio. Collaborate with us and you will benefit from our medical expertise at an operational level, including our understanding on regulations in the different markets thanks to our worldwide exposure. By working together, we can optimize the efficiency of a new compound on the human body.

     

    Sanofi and Regulus Pharmaceuticals form a miRNA discovery and development deal

    In 2010, Sanofi committed with Regulus, a biotechnology company totally devoted to miRNA. miRNA are believed to be extremely important in human development and physiology, as they are supposed to regulate the expression of about a third of all genes, offering a new approach to treating disease.

    This early stage partnership enables the development of therapeutics which could potentially open a new paradigm in the treatment of major diseases and offer an attractive new therapeutic approach for patients.

     

    Right area:

    Go to Our Contacts  

    Upcoming Events

    From October 25 to October 28, 2017
    European Committee for the Treatment and Research in Multiple Sclerosis
    France, Paris

    From November 3 to November 8, 2017
    American College of Rheumatology ACR/ARHP Annual Meeting
    US, San Diego

    From November 6 to November 8, 2017
    Bio Europe Fall
    Germany, Berlin

    From November 7 to November 9, 2017
    Innovation Roundtable Summit 2017
    Denmark, Copenhagen